Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
Floyd F. Petersen net worth and biography

Floyd Petersen Biography and Net Worth

Floyd F. Petersen, M.P.H. has served as a member of our Board of Directors since August 2004. From 1986 to the present, Mr. Petersen has been an Assistant Professor of Biostatistics at Loma Linda University Schools of Public Health, Medicine, and Nursing. From 1990 to 2010, he served as Director of the Loma Linda University Health Research Consulting Group, which consults on health research study design and data analysis. He has personally consulted on over 700 health-related research projects. As a visiting professor, he has taught/consulted in health research in Chad, Romania, PR China, Thailand, Cambodia, PDR Lao, Kenya, Indonesia, Guam, and Russia. Mr. Petersen was a member of the Loma Linda, California City Council from 1990 to 2010 and served as the Mayor of Loma Linda from 1996 to 2006. Mr. Petersen is currently the vice-chair and a board member of Vtrans, a non-profit, quasi-governmental agency, which coordinates all public transportation for the elderly and handicapped in the Inland Empire of Southern California. He earned his M.P.H. in Public Health from Loma Linda University with concentrations in Biostatistics and Health Administration.

What is Floyd F. Petersen's net worth?

The estimated net worth of Floyd F. Petersen is at least $2.66 million as of December 1st, 2022. Mr. Petersen owns 87,108 shares of Amphastar Pharmaceuticals stock worth more than $2,662,892 as of January 30th. This net worth approximation does not reflect any other investments that Mr. Petersen may own. Learn More about Floyd F. Petersen's net worth.

How do I contact Floyd F. Petersen?

The corporate mailing address for Mr. Petersen and other Amphastar Pharmaceuticals executives is 11570 SIXTH STREET, RANCHO CUCAMONGA CA, 91730. Amphastar Pharmaceuticals can also be reached via phone at (909) 980-9484 and via email at [email protected] Learn More on Floyd F. Petersen's contact information.

Has Floyd F. Petersen been buying or selling shares of Amphastar Pharmaceuticals?

Floyd F. Petersen has not been actively trading shares of Amphastar Pharmaceuticals within the last three months. Most recently, Floyd F. Petersen sold 500 shares of the business's stock in a transaction on Thursday, December 1st. The shares were sold at an average price of $30.13, for a transaction totalling $15,065.00. Following the completion of the sale, the director now directly owns 87,108 shares of the company's stock, valued at $2,624,564.04. Learn More on Floyd F. Petersen's trading history.

Who are Amphastar Pharmaceuticals' active insiders?

Amphastar Pharmaceuticals' insider roster includes Richard Koo (Director), Howard Lee (Director), Yakob Liawatidewi (EVP), Ziping Luo (Chairman), William Peters (CFO), Floyd Petersen (Director), Richard Prins (Director), Michael Zasloff (Director), Yongfeng Zhang (Co-Founder), and Rong Zhou (EVP). Learn More on Amphastar Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Amphastar Pharmaceuticals?

In the last year, insiders at the sold shares 26 times. They sold a total of 199,391 shares worth more than $6,840,217.18. The most recent insider tranaction occured on December, 1st when Director Floyd F Petersen sold 500 shares worth more than $15,065.00. Insiders at Amphastar Pharmaceuticals own 27.8% of the company. Learn More about insider trades at Amphastar Pharmaceuticals.

Information on this page was last updated on 12/1/2022.

Floyd F. Petersen Insider Trading History at Amphastar Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2022Sell500$30.13$15,065.0087,108View SEC Filing Icon  
10/3/2022Sell500$28.59$14,295.0088,108View SEC Filing Icon  
8/1/2022Sell500$37.48$18,740.0089,108View SEC Filing Icon  
7/1/2022Sell500$34.78$17,390.0089,608View SEC Filing Icon  
6/1/2022Sell500$37.00$18,500.0085,945View SEC Filing Icon  
5/18/2022Sell9,924$35.05$347,836.2086,445View SEC Filing Icon  
5/2/2022Sell295$35.18$10,378.1076,078View SEC Filing Icon  
4/1/2022Sell500$36.69$18,345.0076,373View SEC Filing Icon  
3/1/2022Sell500$27.27$13,635.00View SEC Filing Icon  
2/1/2022Sell500$24.08$12,040.00View SEC Filing Icon  
1/3/2022Sell500$23.22$11,610.00View SEC Filing Icon  
12/22/2021Sell1,000$22.50$22,500.00View SEC Filing Icon  
6/3/2021Sell10,000$18.65$186,500.0083,354View SEC Filing Icon  
2/1/2021Sell639$18.26$11,668.1473,354View SEC Filing Icon  
12/1/2020Sell500$17.87$8,935.0073,993View SEC Filing Icon  
11/2/2020Sell500$19.84$9,920.0074,493View SEC Filing Icon  
9/1/2020Sell500$19.90$9,950.0075,493View SEC Filing Icon  
8/3/2020Sell500$20.62$10,310.0075,993View SEC Filing Icon  
7/1/2020Sell500$22.27$11,135.0076,493View SEC Filing Icon  
6/1/2020Sell500$18.97$9,485.0071,142View SEC Filing Icon  
5/1/2020Sell500$16.66$8,330.0071,642View SEC Filing Icon  
4/1/2020Sell500$14.36$7,180.0072,142View SEC Filing Icon  
1/2/2020Sell1,000$19.14$19,140.0073,642View SEC Filing Icon  
12/2/2019Sell500$19.25$9,625.0074,642View SEC Filing Icon  
11/1/2019Sell500$19.48$9,740.0075,142View SEC Filing Icon  
10/1/2019Sell500$19.92$9,960.0075,642View SEC Filing Icon  
9/16/2019Sell500$21.75$10,875.0076,142View SEC Filing Icon  
10/4/2017Sell39,312$18.59$730,810.08View SEC Filing Icon  
1/3/2017Sell400$18.61$7,444.0058,717View SEC Filing Icon  
12/1/2016Sell400$20.26$8,104.0059,117View SEC Filing Icon  
10/3/2016Sell400$18.75$7,500.0059,917View SEC Filing Icon  
9/8/2016Sell3,000$19.05$57,150.0060,317View SEC Filing Icon  
8/15/2014Buy3,200$10.35$33,120.00View SEC Filing Icon  
See Full Table

Floyd F. Petersen Buying and Selling Activity at Amphastar Pharmaceuticals

This chart shows Floyd F Petersen's buying and selling at Amphastar Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amphastar Pharmaceuticals Company Overview

Amphastar Pharmaceuticals logo
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Read More

Today's Range

Now: $30.57
Low: $30.32
High: $31.28

50 Day Range

MA: $28.93
Low: $27.99
High: $31.12

2 Week Range

Now: $30.57
Low: $22.07
High: $44.46

Volume

167,000 shs

Average Volume

199,489 shs

Market Capitalization

$1.48 billion

P/E Ratio

20.52

Dividend Yield

N/A

Beta

0.71
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.